Well-differentiated papillary mesothelioma with invasive foci

American Journal of Surgical Pathology

Volumn 38, Issue 7, 2014, Pages 990-998

  Churg, Andrew ^a   Allen, Timothy ^b   Borczuk, Alain C ^e   Cagle, Philip T ^c   Galateau Sallé, Francoise ⁱ   Hwang, Harry ^f   Murer, Bruno ^j   Murty, Vundavalli V ^e   Ordonez, Nelson ^d   Tazelaar, Henry D ^g   Wick, Mark ^h  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e NewYork Presbyterian Hospital   (United States)

^f PHENOPATH LABORATORIES   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF VIRGINIA   (United States)

ⁱ CAEN UNIVERSITY HOSPITAL   (France)

^j OSPEDALE DELL'ANGELO   (Italy)

more..

Author keywords

malignant mesothelioma; p16 deletion; well differentiated papillary mesothelioma

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CHEMISTRY; CHILD; EUROPE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LUNG TUMOR; MALE; MESOTHELIOMA; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NORTH AMERICA; PATHOLOGY; PERITONEUM TUMOR; PREDICTIVE VALUE; TIME; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE;

ADULT; AGED; CELL DIFFERENTIATION; CHILD; EUROPE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NORTH AMERICA; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84902551722     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000200     Document Type: Article

References (20)

1. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Tumors of the Lung, Pleura, Thymus, and Heart. Lyon, France: World Health Organization; 2004.
2. Malpica A, Sant'Ambrogio S, Deavers MT, et al. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases. Am J Surg Pathol. 2012;36: 117-127.
3. Daya D, McCaughey WT. Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer. 1990;65: 292-296.
4. Hoekstra AV, Riben MW, Frumovitz M, et al. Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol. 2005;98: 161-167.
5. Kerrigan SA, Turnnir RT, Clement PB, et al. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients. Cancer. 2002;94: 378-385.
6. Carbone M, Ferris LK, Baumann F, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med. 2012;10:179.
7. Ribeiro C, Campelos S, Moura CS, et al. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation. Ann Oncol. 2013;24: 2147-2150.
8. Cheung M, Talarchek J, Schindeler K, et al. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma. Cancer Genet. 2013;206: 206-210.
9. Chiosea S, Krasinskas A, Cagle PT, et al. Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas. Mod Pathol. 2008;21: 742-747.
10. Kong F, Zhu J, Wu J, et al. dbCRID: a database of chromosomal rearrangements in human diseases. Nucleic Acids Res. 2011;39: D895-D900.
11. Butnor KJ, Sporn TA, Hammar SP, et al. Well-differentiated papillary mesothelioma. Am J Surg Pathol. 2001;25: 1304-1309.
12. Brimo F, Illei PB, Epstein JI. Mesothelioma of the tunica vaginalis: a series of eight cases with uncertain malignant potential. Mod Pathol. 2010;23: 1165-1172.
13. Galateau-Sallé F, Vignaud JM, Burke L, et al. Mesopath group. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol. 2004;28: 534-540.
14. Goldblum J, Hart WR. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol. 1995;19: 1124-1137.
15. Torii I, Hashimoto M, Terada T, et al. Well-differentiated papillary mesothelioma with invasion to the chest wall. Lung Cancer. 2010;67: 244-247.
16. Trpkov K, Barr R, Kulaga A, et al. Mesothelioma of tunica vaginalis of "uncertain malignant potential"-an evolving concept: case report and review of the literature. Diagn Pathol. 2011;6:78.
17. Chen X, Sheng W, Wang J. Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation. Histopathology. 2013;62: 805-813.
18. Bürrig KF, Pfitzer P, Hort W. Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature. Virchows Arch A Pathol Anat Histopathol. 1990;417: 443-447.
19. Churg A, Cagle PT, Roggli VL. Tumors of the Serosal Membranes, Fascicles Series IV. Washington, DC: American Registry of Pathology; 2006.
20. Washimi K, Yokose T, Amitani Y, et al. Well-differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: a case report. Pathol Int. 2013;63: 220-225.